Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Gobardhan Bal, Lakshmi Kanakaraj & Bibhash Chandra Mohanta. (2023) Prediction of pharmacokinetics of an anaplastic lymphoma kinase inhibitor in rat and monkey: application of physiologically based pharmacokinetic model as an alternative tool to minimise animal studies. Xenobiotica 53:12, pages 621-633.
Read now
Read now
Anna Kerins, Marta Koszyczarek, Caroline Smith, Phil Butler, Rob Riley, Vamsi Madgula, Nilkanth Naik, Matthew R. Redinbo & Ian D. Wilson. (2022) The in vitro metabolism and in vivo pharmacokinetics of the bacterial β-glucuronidase inhibitor UNC10201652. Xenobiotica 52:8, pages 904-915.
Read now
Read now
Marike Visser, Matthew J. Zaya, Charles W. Locuson, Dawn M. Boothe & Dawn A. Merritt. (2019) Comparison of predicted intrinsic hepatic clearance of 30 pharmaceuticals in canine and feline liver microsomes. Xenobiotica 49:2, pages 177-186.
Read now
Read now
Khaled A. Shibany, Sabine Tötemeyer, Stefanie L. Pratt & Stuart W. Paine. (2018) The effects of aging on hepatic microsomal scaling factor and hepatocellularity number in the horse. Xenobiotica 48:12, pages 1237-1244.
Read now
Read now
Kellie A. Fay, Patrick N. Fitzsimmons, Alex D. Hoffman & John W. Nichols. (2014) Optimizing the use of rainbow trout hepatocytes for bioaccumulation assessments with fish. Xenobiotica 44:4, pages 345-351.
Read now
Read now
Anna-Karin Sohlenius-Sternbeck, Christopher Jones, Douglas Ferguson, Brian J. Middleton, Denis Projean, Eva Floby, Johan Bylund & Lovisa Afzelius. (2012) Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes. Xenobiotica 42:9, pages 841-853.
Read now
Read now
Leslie C Bell & Jianling Wang. (2012) Probe ADME and Test Hypotheses: a PATH beyond clearance in vitro–in vivo correlations in early drug discovery. Expert Opinion on Drug Metabolism & Toxicology 8:9, pages 1131-1155.
Read now
Read now
Brandon Swift*Nathan D. Pfeifer*Kim L.R. Brouwer. (2010) Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metabolism Reviews 42:3, pages 446-471.
Read now
Read now
Articles from other publishers (40)
Markus Trunzer, Joana Teigão, Felix Huth, Birk Poller, Sandrine Desrayaud, Raquel Rodríguez-Pérez & Bernard Faller. (2024) Improving In Vitro–In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules. Drug Metabolism and Disposition 52:5, pages 345-354.
Crossref
Crossref
Alexandre Barcia Godoi, Natalícia de Jesus Antunes, Kelly Francisco Cunha, Aline Franco Martins, Marilyn A. Huestis & Jose Luiz Costa. (2024) Metabolic Stability and Metabolite Identification of N-Ethyl Pentedrone Using Rat, Mouse and Human Liver Microsomes. Pharmaceutics 16:2, pages 257.
Crossref
Crossref
Amad Uddin, Sonal Gupta, Rumaisha Shoaib, Babita Aneja, Iram Irfan, Kanika Gupta, Neha Rawat, Jill Combrinck, Bhumika Kumar, Mohd Aleem, Phool Hasan, Mukesh C. Joshi, Yashpal S. Chhonker, Muhammad Zahid, Afzal Hussain, Kailash Pandey, Mohamed F. Alajmi, Daryl J. Murry, Timothy J. Egan, Shailja Singh & Mohammad Abid. (2024) Blood-stage antimalarial activity, favourable metabolic stability and in vivo toxicity of novel piperazine linked 7-chloroquinoline-triazole conjugates. European Journal of Medicinal Chemistry 264, pages 115969.
Crossref
Crossref
L.S. Lautz, A.J. Hendriks, J.L.C.M. Dorne, J. Louisse & N.I. Kramer. (2023) Establishing allometric relationships between microsomal protein and cytochrome P450 content with body weight in vertebrate species. Toxicology 486, pages 153429.
Crossref
Crossref
Iram Fatima, Jaya Prakash Uppada, Yashpal S. Chhonker, Saiprasad Gowrikumar, Susmita Barman, Sourav Roy, Kirsten T. Tolentino, Nicholas Palermo, Amar Natarajan, Daniel R. Beauchamp, Alex Vecchio, Daryl J. Murry, Amar B. Singh, Corey R. Hopkins & Punita Dhawan. (2023) Identification and characterization of a first-generation inhibitor of claudin-1 in colon cancer progression and metastasis. Biomedicine & Pharmacotherapy 159, pages 114255.
Crossref
Crossref
Sandra Witta, Keagan P. Collins, Dominique A. Ramirez, Joshua D. Mannheimer, Luke A. Wittenburg & Daniel L. Gustafson. (2023) Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue‐specific drug binding, transport, and metabolism. Pharmacology Research & Perspectives 11:1.
Crossref
Crossref
Natalícia de Jesus Antunes, Gemma Coombes, Kelly Francisco da Cunha, Fernanda de Lima Moreira, Alan C. Pilon, Norberto Peporine Lopes, José Luiz da Costa, Karin Kipper, Lewis Couchman, Atholl Johnston & Gilberto De Nucci. (2022) In vitro metabolism of the new antifungal dapaconazole using liver microsomes. Drug Metabolism and Pharmacokinetics 47, pages 100475.
Crossref
Crossref
S. Cyrus Khojasteh, Harvey Wong, Donglu Zhang & Cornelis E.C.A. HopS. Cyrus Khojasteh, Harvey Wong, Donglu Zhang & Cornelis E.C.A. Hop. 2022. Discovery DMPK Quick Guide. Discovery DMPK Quick Guide
141
161
.
Julia Riede, Birgit M. Wollmann, Espen Molden & Magnus Ingelman-Sundberg. (2021) Primary Human Hepatocyte Spheroids as an In Vitro Tool for Investigating Drug Compounds with Low Hepatic Clearance. Drug Metabolism and Disposition 49:7, pages 501-508.
Crossref
Crossref
Sherry R. Black, John W. Nichols, Kellie A. Fay, Sharlene R. Matten & Scott G. Lynn. (2021) Evaluation and comparison of in vitro intrinsic clearance rates measured using cryopreserved hepatocytes from humans, rats, and rainbow trout. Toxicology 457, pages 152819.
Crossref
Crossref
Mihye Kwon, Jung Bae Park, Miwha Kwon, Jinho Song, Chang Su Yeo & Soo Hyeon Bae. (2021) Pharmacokinetics of 2-phenoxyethanol and its major metabolite, phenoxyacetic acid, after dermal and inhaled routes of exposure: application to development PBPK model in rats. Archives of Toxicology 95:6, pages 2019-2036.
Crossref
Crossref
Michael J. Doerksen, Robert S. Jones, Michael W. H. Coughtrie & Abby C. Collier. (2020) Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation. European Journal of Drug Metabolism and Pharmacokinetics 46:2, pages 173-183.
Crossref
Crossref
Priyanka R. Kulkarni, Amir S. Youssef & Aneesh A. Argikar. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
369
417
.
Yu Lei, Bing Zhang, Dan Liu, Jian Zhao, Xiwen Dai, Jun Gao, Qing Mao, Yao Feng, Jiaxing Zhao, Fengwei Lin, Yulin Duan, Yan Zhang, Ziyang Bao, Yuwei Yang, Yanhua Mou & Shaojie Wang. (2020)
Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y
1
and P2Y
12
as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor
. Journal of Medicinal Chemistry 63:24, pages 15752-15772.
Crossref
Crossref
Wafaa N. Aldhafiri, Yashpal S. Chhonker, Yuning Zhang, Don W. Coulter, Timothy R. McGuire, Rongshi Li & Daryl J. Murry. (2020) Assessment of Tissue Distribution and Metabolism of MP1, a Novel Pyrrolomycin, in Mice Using a Validated LC-MS/MS Method. Molecules 25:24, pages 5898.
Crossref
Crossref
Elaina M. Kenyon, Christopher Eklund, Rex A. Pegram & John C. Lipscomb. (2020) Comparison of in vivo derived and scaled in vitro metabolic rate constants for several volatile organic compounds (VOCs). Toxicology in Vitro 69, pages 105002.
Crossref
Crossref
Morten Sandvik, Christopher O. Miles, Alistair L. Wilkins & Christiane Fæste. (2020) In vitro hepatic biotransformation of the algal toxin pectenotoxin-2. Toxicon: X 6, pages 100031.
Crossref
Crossref
Silvio Uhlig, Lada Ivanova, Pauline Voorspoels & Christiane Kruse Fæste. (2020) In Vitro Toxicokinetics and Phase I Biotransformation of the Mycotoxin Penitrem A in Dogs. Toxins 12:5, pages 293.
Crossref
Crossref
Gábor Wágner, Tamara A. M. Mocking, Marta Arimont, Gustavo Provensi, Barbara Rani, Bruna Silva-Marques, Gniewomir Latacz, Daniel Da Costa Pereira, Christina Karatzidou, Henry F. Vischer, Maikel Wijtmans, Katarzyna Kieć-Kononowicz, Iwan J. P. de Esch & Rob Leurs. (2019)
4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H
3
Receptor Agonists with in Vivo Central Nervous System Activity
. Journal of Medicinal Chemistry 62:23, pages 10848-10866.
Crossref
Crossref
Dominique A. Ramirez, Keagan P. Collins, Allister E. Aradi, Katherine A. Conger & Daniel L. Gustafson. (2019) Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics. Drug Metabolism and Disposition 47:3, pages 257-268.
Crossref
Crossref
Yashpal S. Chhonker, Richard L. Sleightholm & Daryl J. Murry. (2018)
Bioanalytical method development and validation of moxidectin in plasma by LC–MS/MS: Application to
in vitro
metabolism
. Biomedical Chromatography 33:2.
Crossref
Crossref
Alan R. Wolfe, R. Jeffrey Neitz, Mark Burlingame, Brian M. Suzuki, KC Lim, Mark Scheideler, David L. Nelson, Leslie Z. Benet & Conor R. Caffrey. (2018) TPT sulfonate, a single, oral dose schistosomicidal prodrug: In vivo efficacy, disposition and metabolic profiling. International Journal for Parasitology: Drugs and Drug Resistance 8:3, pages 571-586.
Crossref
Crossref
Christiane Kruse Fæste, Lada Ivanova, Amin Sayyari, Ulrik Hansen, Tore Sivertsen & Silvio Uhlig. (2018) Prediction of deoxynivalenol toxicokinetics in humans by in vitro-to-in vivo extrapolation and allometric scaling of in vivo animal data. Archives of Toxicology 92:7, pages 2195-2216.
Crossref
Crossref
Daniel Scotcher, Sarah Billington, Jay Brown, Christopher R. Jones, Colin D. A. Brown, Amin Rostami-Hodjegan & Aleksandra Galetin. (2017) Microsomal and Cytosolic Scaling Factors in Dog and Human Kidney Cortex and Application for In Vitro-In Vivo Extrapolation of Renal Metabolic Clearance. Drug Metabolism and Disposition 45:5, pages 556-568.
Crossref
Crossref
Oliver J.D. Hatley, Christopher R. Jones, Aleksandra Galetin & Amin Rostami‐Hodjegan. (2017) Optimization of intestinal microsomal preparation in the rat: A systematic approach to assess the influence of various methodologies on metabolic activity and scaling factors. Biopharmaceutics & Drug Disposition 38:3, pages 187-208.
Crossref
Crossref
Oliver J.D. Hatley, Christopher R. Jones, Aleksandra Galetin & Amin Rostami‐Hodjegan. (2017) Quantifying gut wall metabolism: methodology matters. Biopharmaceutics & Drug Disposition 38:2, pages 155-160.
Crossref
Crossref
Ricardo Marcos, Célia Lopes, Fernanda Malhão, Carla Correia‐Gomes, Sónia Fonseca, Margarida Lima, Rolf Gebhardt & Eduardo Rocha. (2016) Stereological assessment of sexual dimorphism in the rat liver reveals differences in hepatocytes and Kupffer cells but not hepatic stellate cells. Journal of Anatomy 228:6, pages 996-1005.
Crossref
Crossref
J. Nicolai, T. De Bruyn, L. Thevelin, P. Augustijns & P. Annaert. (2015) Transport-Metabolism Interplay of Atazanavir in Rat Hepatocytes. Drug Metabolism and Disposition 44:3, pages 389-397.
Crossref
Crossref
Dennis A. Smith & Thomas A. Baillie. 2015. Attrition in the Pharmaceutical Industry. Attrition in the Pharmaceutical Industry
83
105
.
J. Nicolaï, T. De Bruyn, P. P. Van Veldhoven, J. Keemink, P. Augustijns & P. Annaert. (2015) Verapamil hepatic clearance in four preclinical rat models: towards activity‐based scaling. Biopharmaceutics & Drug Disposition 36:7, pages 462-480.
Crossref
Crossref
Hardik Chandasana, Yashpal S. Chhonker, Veenu Bala, Yarra D. Prasad, Telaprolu K. Chaitanya, Vishnu L. Sharma & Rabi S. Bhatta. (2015) Pharmacokinetic, bioavailability, metabolism and plasma protein binding evaluation of NADPH-oxidase inhibitor apocynin using LC–MS/MS. Journal of Chromatography B 985, pages 180-188.
Crossref
Crossref
Aki T. Heikkinen, Arno Friedlein, Mariette Matondo, Oliver J. D. Hatley, Aleksanteri Petsalo, Risto Juvonen, Aleksandra Galetin, Amin Rostami-Hodjegan, Ruedi Aebersold, Jens Lamerz, Tom Dunkley, Paul Cutler & Neil Parrott. (2014) Quantitative ADME Proteomics – CYP and UGT Enzymes in the Beagle Dog Liver and Intestine. Pharmaceutical Research 32:1, pages 74-90.
Crossref
Crossref
Yoshihiro Shibata, Jiro Kuze & Masato Chiba. (2014) Utility of Cryopreserved Hepatocytes Suspended in Serum to Predict Hepatic Clearance in Dogs and Monkeys. Drug Metabolism and Pharmacokinetics 29:2, pages 168-176.
Crossref
Crossref
John W. Nichols, Duane B. Huggett, Jon A. Arnot, Patrick N. Fitzsimmons & Christina E. Cowan‐Ellsberry. (2013) Toward improved models for predicting bioconcentration of well‐metabolized compounds by rainbow trout using measured rates of in vitro intrinsic clearance. Environmental Toxicology and Chemistry 32:7, pages 1611-1622.
Crossref
Crossref
Aki T. Heikkinen, Arno Friedlein, Jens Lamerz, Peter Jakob, Paul Cutler, Stephen Fowler, Tara Williamson, Roberto Tolando, Thierry Lave & Neil Parrott. (2012) Mass Spectrometry-Based Quantification of CYP Enzymes to Establish In Vitro/In Vivo Scaling Factors for Intestinal and Hepatic Metabolism in Beagle Dog. Pharmaceutical Research 29:7, pages 1832-1842.
Crossref
Crossref
Peter Ballard & Malcolm Rowland. (2011)
Correction for Nonspecific Binding to Various Components of Ultrafiltration Apparatus and Impact on Estimating In Vivo Rat Clearance for a Congeneric Series of 5-Ethyl, 5-
n
-Alkyl Barbituric Acids
. Drug Metabolism and Disposition 39:12, pages 2165-2168.
Crossref
Crossref
Christiane K. Fæste, Lada Ivanova & Silvio Uhlig. (2011) In Vitro Metabolism of the Mycotoxin Enniatin B in Different Species and Cytochrome P450 Enzyme Phenotyping by Chemical Inhibitors. Drug Metabolism and Disposition 39:9, pages 1768-1776.
Crossref
Crossref
Siamak Cyrus Khojasteh, Harvey Wong & Cornelis E.C.A. HopSiamak Cyrus Khojasteh, Harvey Wong & Cornelis E. C. A. Hop. 2011. Drug Metabolism and Pharmacokinetics Quick Guide. Drug Metabolism and Pharmacokinetics Quick Guide
127
144
.
Chien-Ming Li, Yan Lu, Ramesh Narayanan, Duane D. Miller & James T. Dalton. (2010) Drug Metabolism and Pharmacokinetics of 4-Substituted Methoxybenzoyl-aryl-thiazoles. Drug Metabolism and Disposition 38:11, pages 2032-2039.
Crossref
Crossref
Chunshan Gui & Bruno Hagenbuch. (2010) Cloning/characterization of the canine organic anion transporting polypeptide 1b4 (Oatp1b4) and classification of the canine OATP/SLCO members. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 151:3, pages 393-399.
Crossref
Crossref